Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chandrakumar Shanmugam

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2009
Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinomaVenkat R Katkoori, Xu Jia, Chandrakumar Shanmugam, et al.
Cancer Medicine|March 14, 2023
Immunophenotypic profiles and prognosis for colorectal mucinous adenocarcinomas are dependent on anatomic locationChirag Patel, Michael Behring, Sameer Al Diffalha, et al.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2021
Meta-Analysis of Robustness of COVID-19 Diagnostic Kits During Early PandemicChandrakumar Shanmugam, Michael Behring, Vishwas Luthra, et al.
Cancer|November 26, 2009
Effect of comorbidity and body mass index on the survival of African-American and Caucasian patients with colon cancerRobert B Hines, Chandrakumar Shanmugam, John W Waterbor, et al.
Plos One|February 8, 2019
The combined survival effect of codon 72 polymorphisms and p53 somatic mutations in breast cancer depends on race and molecular subtypeShantel Hebert-Magee, Han Yu, Michael Behring, et al.
Journal of Digestive Diseases and Hepatology|February 17, 2017
Association between Hepatitis C Virus Infection, p53 Phenotypes, and Gene Variants of Adenomatous Polyposis Coli in Hepatocellular CarcinomasLeona N Council, Chandrakumar Shanmugam, Esther A Suswam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2013
The prognostic value of microRNAs varies with patient race/ethnicity and stage of colorectal cancerLiselle C Bovell, Chandrakumar Shanmugam, Balananda-Dhurjati K Putcha, et al.
Oncotarget|April 21, 2017
Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancerXu Jia, Chandrakumar Shanmugam, Ravi K Paluri, et al.
Journal of Gastrointestinal Oncology|July 20, 2012
Bax expression is a candidate prognostic and predictive marker of colorectal cancerVenkat R Katkoori, Catalina Suarez-Cuervo, Chandrakumar Shanmugam, et al.
Plos One|January 26, 2012
Prognostic significance and gene expression profiles of p53 mutations in microsatellite-stable stage III colorectal adenocarcinomasVenkat R Katkoori, Chandrakumar Shanmugam, Xu Jia, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2009
Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinomaVenkat R Katkoori, Xu Jia, Chandrakumar Shanmugam, et al.
Cancer Medicine|March 14, 2023
Immunophenotypic profiles and prognosis for colorectal mucinous adenocarcinomas are dependent on anatomic locationChirag Patel, Michael Behring, Sameer Al Diffalha, et al.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2021
Meta-Analysis of Robustness of COVID-19 Diagnostic Kits During Early PandemicChandrakumar Shanmugam, Michael Behring, Vishwas Luthra, et al.
Cancer|November 26, 2009
Effect of comorbidity and body mass index on the survival of African-American and Caucasian patients with colon cancerRobert B Hines, Chandrakumar Shanmugam, John W Waterbor, et al.
Plos One|February 8, 2019
The combined survival effect of codon 72 polymorphisms and p53 somatic mutations in breast cancer depends on race and molecular subtypeShantel Hebert-Magee, Han Yu, Michael Behring, et al.
Journal of Digestive Diseases and Hepatology|February 17, 2017
Association between Hepatitis C Virus Infection, p53 Phenotypes, and Gene Variants of Adenomatous Polyposis Coli in Hepatocellular CarcinomasLeona N Council, Chandrakumar Shanmugam, Esther A Suswam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2013
The prognostic value of microRNAs varies with patient race/ethnicity and stage of colorectal cancerLiselle C Bovell, Chandrakumar Shanmugam, Balananda-Dhurjati K Putcha, et al.
Oncotarget|April 21, 2017
Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancerXu Jia, Chandrakumar Shanmugam, Ravi K Paluri, et al.
Journal of Gastrointestinal Oncology|July 20, 2012
Bax expression is a candidate prognostic and predictive marker of colorectal cancerVenkat R Katkoori, Catalina Suarez-Cuervo, Chandrakumar Shanmugam, et al.
Plos One|January 26, 2012
Prognostic significance and gene expression profiles of p53 mutations in microsatellite-stable stage III colorectal adenocarcinomasVenkat R Katkoori, Chandrakumar Shanmugam, Xu Jia, et al.
Pageof 3